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Abstract
Purpose This study describes swallow-related quality of life (SWAL-QOL) in patients with myotonic dystrophy type 1 
(DM1) and investigates its association with swallowing function and disease severity.
Methods A SWAL-QOL questionnaire was completed by 75 DM1 patients and 25 healthy control subjects. The severity 
of the disease was evaluated using the muscular impairment rating scale (MIRS). Twenty-eight DM1 patients underwent a 
videofluroscopic swallowing examination (VFS). Spearman’s correlation coefficient was used to measure the direction and 
strength of associations.
Results The SWAL-QOL median scores were significantly lower for the DM1 group than for the healthy control group. The 
scores for the majority of the SWAL-QOL domains were lower in patients with proximal muscular weakness (MIRS 4 and 
5). Postswallow vallecular pooling and piecemeal deglutition were the most impaired VFS outcome variables.
Conclusion Our results suggest that a multidimensional swallowing assessment is recommended for DM1 patients as SWAL-
QOL and VFS measure different aspects of the swallowing function, thus providing complementary information.
Keywords Deglutition disorders · Dysphagia · Myotonic dystrophy · Quality of life · Videofluoroscopy
Introduction
Myotonic dystrophy type 1 (DM1) is the most common 
form of muscular dystrophy in adults and is dominantly 
inherited. The clinical manifestations, which are highly 
variable, include myotonia, muscular dystrophy, cataracts, 
and involvement of other organs such as the heart, endo-
crine system, and brain. In addition, cognitive dysfunction, 
reduced initiative, inactivity, and apathy are consistent with 
the disease, and these characteristics have healthcare impli-
cations for DM1 patients [1]. Fatigue and reduced mobility 
have been identified as the symptoms most disturbing to 
their daily life [2]. Moreover, since the weakness present in 
many parts of the body also affects oropharyngeal muscles, 
swallowing impairment is prevalent in DM1 [3, 4].
DM1 patients report lower QoL than healthy subjects and 
these scores were associated to fatigue, daytime sleepiness, 
and muscular impairment [5, 6]. Although these prior stud-
ies have evaluated the influence of its physical and psycho-
logical manifestations on health-related quality of life (QoL), 
little is known about the impact of swallowing impairment 
on health-related QoL in DM1 patients. Besides fulfilling a 
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basic need, eating has significant psychological and social 
functions. An evaluation of swallowing should therefore 
cover not only its physiological aspects but should also take 
patients’ perception into account. To that end, data would 
have to be gathered on the impact of swallowing impairment 
on health-related QoL. A better understanding of how DM1 
patients perceive and cope with oropharyngeal dysphagia 
could improve the guidelines for clinical interventions and 
rehabilitation programs. From that perspective, the aim of 
this study was twofold: (a) to describe swallow-related QoL 
in dysphagic patients with DM1, and (b) to investigate the 
relationship between swallow-related QoL with swallowing 
function on the one hand and disease severity on the other 
hand.
Material and methods
Participants
Genetically confirmed DM1 patients were prospectively 
included in this study and were consecutively recruited 
from the multidisciplinary outpatient clinic for dysphagia 
in the Maastricht University Medical Center (MUMC). All 
recruited patients were referred for swallowing examination 
on the grounds of signs or symptoms of deglutition disor-
ders, i.e., cough while eating, sensation of food getting stuck 
in the throat, long time to finish a meal, etc. Individuals were 
excluded if they had any other neurological disease (besides 
DM1) or head and neck cancer; had received speech therapy 
in the past (to exclude benefit of treatment and attention); 
had cognitive impairment [mini mental state examination 
(MMSE) < 23]; or had undergone surgery of critical struc-
tures involved in swallowing (tongue, larynx, etc.) or the 
central nervous system. Patients over eighty years old were 
excluded due to the possibility of presenting dysphagia as 
a result of aging (presbyphagia). Healthy participants with-
out swallowing complaints were recruited from the local 
community to serve as a control group. Informed consent 
was obtained from all participants. The study protocol was 
approved by the medical ethics committee of the MUMC.
Measures
Disease severity
The neuromuscular involvement of the disease was scored 
by a neurologist using the muscular impairment rating scale 
(MIRS) [7]. This scale expresses a clinical assessment of the 
progression of muscular impairment (distal to proximal) in 
DM1. It classifies the degree of impairment in an ordinal 
scale ranging from one (no muscular impairment) to five 
(severe proximal weakness).
Swallow‑related QoL (SWAL‑QOL)
The SWAL-QOL survey was designed to evaluate the 
impact of swallowing problems on the health-related QoL 
of patients with oropharyngeal dysphagia [8]. The ques-
tionnaire was translated into the Dutch language and then 
validated [9]. The SWAL-QOL was designed to assess 
eight domains of swallow-related QoL (general burden, 
food selection, eating duration, eating desire, fear of 
eating, communication, social functioning, and mental 
health), two concepts of generic QoL (fatigue and sleep), 
and a dysphagia clinical symptom scale (symptom score). 
The score of each domain is calculated based on two or 
more questions. The score per domain ranges from 0 
(extremely impaired) to 100 (no impairment).
Swallowing function
Swallowing function was evaluated by performing a vide-
ofluoroscopic swallowing study (VFS). During the VFS, 
the patients were offered one trial of thin liquid (low-den-
sity barium—40% w/v(weight/volume) and one trial of 
thick liquid (50 cc applesauce + 150 gr barium powder) 
followed by one bite-sized cracker coated with barium 
paste. All measurements followed the same protocol [10]. 
Each participant swallowed the bolus consistencies upon 
command and in the same sequence (thin liquid, thick liq-
uid, and bite-sized cracker). The VFS was performed in a 
lateral position. The images were obtained with a Philips 
Diagnost 97 system (Philips Medical Systems, Eindhoven, 
The Netherlands) and recorded on DVD at 30 frames per 
second. All swallows were analyzed by two experienced 
raters trained in the VFS scoring system. They scored four 
ordinal variables: piecemeal deglutition (sequential swal-
lowing on the same bolus), postswallow vallecular and/
or pyriform pooling (bolus retention in the valleculae or 
pyriform sinus after swallowing), laryngeal penetration 
(bolus in the laryngeal vestibule above or on the level of 
the vocal folds) and aspiration (bolus passes below the 
vocal folds) [4]. The raters were blinded to each other’s 
results (independent rating) and to the patients’ medical 
history. A written manual with well-defined descriptions 
of the scales’ levels was available during the rating pro-
cess. The swallows were scored in randomized order at 
varying speed (slow motion, normal, up to frame-by-frame 
speed) using the software program Windows Movie Maker 
version 5.1 (Microsoft Corporation, Redmond, WA, USA). 
The raters were advised to limit the duration of the meas-
urement sessions (max. two hours) to avoid fatigue. To 
obtain intrarater agreement, each rater repeated the meas-
urement of 39 swallows within a period of two weeks. The 
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scores of the rater with the highest indices of intrarater 
agreement were used for subsequent statistical analysis.
Statistical analysis
Raters’ agreement was analyzed with a weighted Kappa (for 
ordinal variables). The internal consistency of the SWAL-
QOL was analyzed using Cronbach’s alpha. The partici-
pants’ characteristics are presented as absolute numbers/
percentages for categorical variables and median and 25th; 
75th percentiles for continuous variables. Spearman’s cor-
relation was used to measure the direction and strength of 
correlations. The two groups (DM1 patients and healthy 
control subjects) were compared with the Mann–Whitney 
U test. The internal consistency of the SWAL-QOL was ana-
lyzed using Cronbach’s alpha. Significance level was 5%. 
Because of the large number of null-hypothesis tests con-
ducted, especially the many pair-wise correlations, p values 
were adjusted for multiple-testing with False Discovery Rate 
(FDR) correction.
Results
Characteristics of the participants
SWAL-QOL was completed by 25 healthy control subjects 
and 75 DM1 patients. The mean age in the control group 
was 45.6 years, ranging from 22 to 71, and 52% were men. 
In the patient group, the mean age was 43.43, ranging from 
21 to 73, and 55% were men. Most DM1 patients presented 
mild to moderate proximal muscular weakness (MIRS 4, 
N = 22) or severe proximal muscular weakness (MIRS 5, 
N = 23). Eight patients presented minimal signs of muscular 
impairment (MIRS 2).
All healthy control subjects and over 68% of the patients 
completed the questionnaire by themselves. The other 
32% of the patients received help, mainly with reading the 
questions and/or writing the answers. Most of the patients 
reported having a normal diet without texture modification.
SWAL‑QOL
The scores of all SWAL-QOL domains were significantly 
lower for the DM1 group than for the healthy control group 
(Table 1). In the healthy control group most of the SWAL-
QOL domains showed a skewed distribution with an accen-
tuated ceiling effect. No floor effect was observed. In the 
patients’ group, three SWAL-QOL domains presented a 
higher percentage of ceiling effect: ‘social functioning’ 
(56%), ‘eating desire’ (48%), and ‘fear of eating’ (48%). The 
dysphagia symptoms most frequently reported in the study 
were: ‘coughing’, ‘having to clear the throat’, and ‘food 
sticking in the throat’. No correlations were found between 
age, gender, and each of the eleven SWAL-QOL domains.
VFS measurements in the DM1 group
The VFS outcome measurements of the first subset of 28 
DM1 patients were analyzed. Twenty of these patients were 
male and the mean age was 46.5 years. MIRS ranged from 
1 to 5, median 5 (25th; 75th percentiles: 3.25; 5). Intra- and 
interrater agreement indices were substantial to almost per-
fect for all measured VFS variables. Analysis of the visu-
operceptual variables revealed that swallowing function 
was impaired in the majority of the patients. The variable 
showing the highest level of impairment was postswallow 
Table 1  Differences on SWAL-
QOL domains between DM1 
patients and healthy subjects
a Mann–Whitney U test; significance level: p value < 0.05
b Cronbach’s α > 0.7
c Values are median and 25th;75th percentiles
SWAL-QOL domains DM1 patients N = 75 Healthy control 
subjects N = 25
p  valuea Cronbach’s αb
Burden 88 (63; 100)c 100 (100; 100)c 0.001 0.90
Food selection 75 (50; 100) 100 (100; 100) 0.001 0.83
Eating duration 50 (25; 88) 100 (94; 100) 0.001 0.85
Eating desire 92 (58; 100) 100 (100; 100) 0.003 0.87
Fear of eating 94 (75; 100) 100 (100; 100) 0.001 0.84
Sleep 75 (50; 100) 88 (75; 100) 0.031 0.84
Fatigue 42 (25; 75) 92 (83; 100) 0.001 0.88
Communication 75 (63; 88) 100 (100; 100) 0.001 0.83
Mental health 95 (75; 100) 100 (100; 100) 0.001 0.88
Social functioning 100 (75; 100) 100 (100; 100) 0.001 0.94
Symptom score 66 (54; 86) 100 (95.5; 100) 0.001 0.94
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vallecular pooling (Fig. 1). The percentages of patients with 
a score of two or more on the variable piecemeal deglutition 
were 46.1% (thin liquid), 48.1% (thick liquid), and 66.6% 
(cracker). One patient aspirated thin liquid and two patients 
aspirated both thin and thick liquid.
Relationship between disease severity, SWAL‑QOL, 
and VFS measurements in the DM1 group
The scores for the majority of the SWAL-QOL domains 
were lower in patients with proximal muscular weakness 
(MIRS 4 and 5). However, when comparing the score of 
each SWAL-QOL domain between the muscular impair-
ment severity levels (MIRS 1 to 5), the differences did 
not reach statistical significance. Spearman’s correla-
tion coefficient between severity of muscular impairment 
(MIRS) and SWAL-QOL showed a weak correlation in four 
domains: ‘general burden’ (rho = – 0. 241), ‘eating duration’ 
(rho = – 0.287), ‘fear of eating’ (rho = – 0.275), and ‘symp-
tom score’ (rho = – 0.322). Two VFS outcome measurements 
correlated with MIRS: piecemeal deglutition of bite-sized 
cracker (rho = 0.466) and postswallow pyriform sinus pool-
ing of thick liquid (rho = 0.376). Although these correlations 
were significant in the preliminary statistical analyses, none 
of them reached the level of significance after FDR correc-
tion for multiple-testing.
Relationship between VFS measurements 
and SWAL‑QOL
The SWAL-QOL domains ‘general burden’, ‘eating dura-
tion’, ‘eating desire’, and ‘fear of eating’, showed moderate 
correlation with VFS outcome measurements, though incon-
clusive after FDR correction (Table 2).
Discussion
This study describes swallowing-related QoL in DM1 
patients and evaluates the correlation between patient-
reported impact of dysphagia on QoL, instrumental assess-
ment of the swallowing function, and disease severity. The 
differences in the SWAL-QOL scores between the healthy 
control group and DM1 patients were significant and are in 
concordance with previous studies reporting lower SWAL-
QOL scores in dysphagic subjects [8, 11]. Conversely, cor-
relations between VFS outcome measurements, on the one 
hand, and SWAL-QOL domains and disease severity, on the 
other, were inconclusive after multiple testing correction.
In the DM1 group, the SWAL-QOL domain with the low-
est scores (representing more impairment) was ‘fatigue’, fol-
lowed by ‘eating duration’, and ‘symptom score’. The high 
frequency of fatigue found in this study is not surprising 
and is consistent with results from other studies [2, 12, 13]. 
In the domain ‘eating duration’, lower scores representing a 
longer amount of time to eat a meal were frequently found. 
A longer duration may be linked to weakness of the oral 
and pharyngeal muscles in DM1 patients [14]. Moreover, 
weak oropharyngeal muscles can impair the propulsion of 
the bolus from the mouth to the esophagus. An ineffective 
bolus propulsion usually generates repeated swallows in a 
physiological attempt to clear the residue from the oral cav-
ity and pharynx [15]. As a consequence, a frequent occur-
rence of repeated swallows or ‘piecemeal deglutition’ may 
extend the duration of the meal.
Disease severity has been considered one of the main fac-
tors of health-related QoL in patients with neuromuscular 
disease. The impact of the progression of the disease on vari-
ous aspects of health-related QoL, other than swallowing, 
has already been reported [5, 6, 16]. Our results showed a 
weak relationship between the severity of muscular impair-
ment and SWAL-QOL domains as well as the severity of 
swallowing impairment. The hypothesis that the severity 
of the muscular impairment would have an impact on the 
SWAL-QOL domains should be further investigated in a 
longitudinal study.
This study analyzed a correlation between SWAL-QOL 
domains and VFS outcomes measurements to ascertain 
whether patients’ perception of the impact of dysphagia 
on QoL directly reflects the severity of the swallowing 
Fig. 1  Frequency distribution of DM1 patients (N = 28) per consist-
ency on three VFS outcome variables. The y-axis represents the fre-
quency of occurrence in absolute numbers of patients. The x-axis 
indicates the consistency of each swallow. For the variables ‘val-
lecular and pyriform sinus pooling’, trace of pooling up to filling of 
less than 50% of the vallecular space/pyriform sinus is represented 
as moderate impairment. Filling of more than 50% of the vallecular 
space/pyriform sinus is represented as severe impairment. For the 
variable ‘penetration and aspiration’, penetration is represented as 
moderate impairment and aspiration as severe impairment
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impairment. The moderate correlation between these two 
assessment approaches, lacking statistical significance 
after adjustment for multiple testing, suggests that patients 
with an impaired swallowing function not always report a 
decrease in their swallow-related QoL. Besides instrumen-
tal swallowing assessment using VFS the intrinsic charac-
teristics of a tool that evaluated the impact of swallowing 
impairment on QoL and the variety of aspects involved in 
the eating process should also be considered. SWAL-QOL 
scores are based on patients’ personal perspective on the 
impact of dysphagia and are not a direct reflection of their 
physiological swallowing ability. Social, behavioral, and 
psychological aspects are entangled when feeding is self-
assessed, and patients have different levels of perception 
and tolerance when facing a physical limitation. Especially 
in a disease with a slow progression such as DM1, patients 
adapt their actions and behavior, so their attitude can influ-
ence the scores on SWAL-QOL. In that light, our study 
confirms in the DM1 population the findings from a previ-
ous study that investigated a broad variety of dysphagic 
patients: SWAL-QoL and VFS measure different aspects 
or dimensions of the swallowing function, thus provid-
ing complementary information [17]. Moreover, it rein-
forces the importance of a multidimensional swallowing 
assessment, including an instrumental examination, such 
as fiberoptic endoscopic evaluation of swallowing (FEES) 
and/or VFS, in all DM1 patient with dysphagia.
SWAL-QOL provides valuable information on how these 
patients perceive and cope with their swallowing disability. 
This information is essential for rehabilitation programs, 
as it can guide the clinicians’ approach when proposing 
changes in food consistencies or an exercise program. Know-
ing which QoL aspects are impacted by dysphagia allow 
clinicians to look beyond the swallowing function, focus-
ing on interventions that would have an effect on QoL. For 
instance, as fatigue and duration of the meals were SWAL-
QOL domains affected by dysphagia in DM1 patients, the 
rehabilitation plan should include strategies to shorten the 
time patients spend eating a meal. Strategies such as, bolus 
modification, changes in food portion sizes, frequency 
of meals, etc. The success of a rehabilitation program is 
dependent on patients’ commitment, and changes in eating 
behavior are only possible if patients recognize the severity 
and the limitations imposed by their swallowing problem.
Methodological limitations
The present study has some methodological limitations 
that should be taken into consideration. Though the DM1 
patients scored significantly lower than the control group 
and all patients reported one or more dysphagia symptoms, 
most SWAL-QOL domains were not scored as severely 
impaired. The homogeneity of the SWAL-QOL scores, 
Table 2   Correlation between 
SWAL-QOL domains and VFS 
outcomes 
The level of significance (p) before and after(*) the correction for multiple tests is presented
VFS SWAL-QOL
Eating duration Eating desire Fear of eating General burden
Thin liquid
 Postswallow vallecular pooling 0.484
p = 0.025
p = 0.123*
 Postswallow pyriform sinus pooling – 0.438
p = 0.012
p = 0.193*
Thick liquid
 Postswallow vallecular pooling – 0.410
p = 0.034
p = 0.180*
 Postswallow pyriform sinus pooling – 0.453
p = 0.020
p = 0.228*
Cracker
 Postswallow pyriform sinus pooling 0.532
p = 0.005
p = 0.064*
 Piecemeal deglutition – 0.478
p = 0.012
p = 0.123*
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especially those with ceiling effects, is bound to have attenu-
ated statistical correlations due to the restriction of range 
effect.
Conclusion
SWAL-QOL provides information on how DM1 patients 
perceive their swallowing impairment and on the impact of 
dysphagia on their swallow-related QoL. There was no cor-
relation between the severity of muscular impairment on 
one hand and VFS outcome and SWAL-QOL scores on the 
other. Interestingly, the weak to moderate, but eventually 
inconclusive correlations between VFS and SWAL-QOL 
outcomes suggests that these two tools measure different 
aspects of dysphagia in DM1 patients. If that is indeed the 
case, SWAL-QOL should not be taken as an indicator of the 
severity of dysphagia for these patients. However, SWAL-
QOL should be part of the swallowing assessment as it pro-
vides complimentary information that could improve dys-
phagia management.
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